NYSE Proposal Suspends Certain Shareholder Approvals and Listing Requirements as a Result of COVID-19


On April 3, 2020, the New York Stock Exchange submitted two proposals with the U.S. Securities and Exchange Commission that would temporarily suspend: (1) certain shareholder approval requirements for private placements; and (2) listing requirements regarding a company’s market capitalization and share price. 

Citing the use of private placements and purported “barriers” resulting from shareholder approval rules during the 2008 Financial Crisis, the NYSE has proposed a waiver of shareholder approval rules in order to provide companies with the ability to raise cash quickly regardless of the amount being raised or the number of private investors, including related parties.  Notably, the waiver would only be available if the private placements were approved by the company’s audit committee or a committee of independent directors.

Additionally, the NYSE has proposed suspending its listing requirements, which require companies to have a $50 million market capitalization and a 30-day average share price above $1.  If approved, companies would not be required to file disclosures regarding their non-compliance nor would the companies be required to develop a compliance plan.  In support of this proposal, the NYSE noted that the very same $1 share price waiver was utilized during the 2008 Financial Crisis.

As proposed, the temporary suspensions would remain in place until June 30, 2020.

For more information, the proposals can be found here.

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Georgia and Pennsylvania.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

Tags: faruqi & faruqi, investigation, news, litigation, settlement notice, case, faruqi law, faruqi blog, faruqilaw, Michael Van Gorder, derivative litigation Faruqi & Faruqi Faruqi & Faruqi

New York office
Tel: (212) 983-9330
Fax: (212) 983-9331

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania